Microfluidic: An innovative tool for efficient cell sorting

被引:119
作者
Autebert, Julien [1 ]
Coudert, Benoit [1 ]
Bidard, Francois-Clement [2 ]
Pierga, Jean-Yves [2 ]
Descroix, Stephanie [1 ]
Malaquin, Laurent [1 ]
Viovy, Jean-Louis [1 ]
机构
[1] Univ Paris 06, Inst Curie, CNRS, UMR 168, F-75005 Paris, France
[2] Inst Curie, Dept Med Oncol, F-75005 Paris, France
关键词
Microfluidic; Immunomagnectic separation; Circulating tumor cells; Biochemical cell sorting; Label-free physical cell sorting; CIRCULATING TUMOR-CELLS; CONTINUOUS PARTICLE SEPARATION; PINCHED FLOW FRACTIONATION; METASTATIC BREAST-CANCER; RED-BLOOD-CELLS; PERIPHERAL-BLOOD; ENDOTHELIAL-CELLS; LAMINAR-FLOW; WHOLE-BLOOD; MATERNAL CIRCULATION;
D O I
10.1016/j.ymeth.2012.07.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
At first mostly dedicated to molecular analysis, microfluidic systems are rapidly expanding their range of applications towards cell biology, thanks to their ability to control the mechanical, biological and fluidic environment at the scale of the cells. A number of new concepts based on microfluidics were indeed proposed in the last ten years for cell sorting. For many of these concepts, progress remains to be done regarding automation, standardization, or throughput, but it is now clear that microfluidics will have a major contribution to the field, from fundamental research to point-of-care diagnosis. We present here an overview of cells sorting in microfluidics, with an emphasis on circulating tumor cells. Sorting principles are classified in two main categories, methods based on physical properties of the cells, such as size, deformability, electric or optical properties, and methods based on biomolecular properties, notably specific surface antigens. We document potential applications, discuss the main advantages and limitations of different approaches, and tentatively outline the main remaining challenges in this fast evolving field. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:297 / 307
页数:11
相关论文
共 113 条
[1]   Detection and characterization of putative metastatic precursor cells in cancer patients [J].
Alix-Panabieres, Catherine ;
Vendrell, Jean-Pierre ;
Pelle, Olivier ;
Rebillard, Xavier ;
Riethdorf, Sabine ;
Mueller, Volkmar ;
Fabbro, Michel ;
Pantel, Klaus .
CLINICAL CHEMISTRY, 2007, 53 (03) :537-539
[2]   Sorting cells by size, shape and deformability [J].
Beech, Jason P. ;
Holm, Stefan H. ;
Adolfsson, Karl ;
Tegenfeldt, Jonas O. .
LAB ON A CHIP, 2012, 12 (06) :1048-1051
[3]   The multifaceted circulating endothelial cell in cancer: towards marker and target identification [J].
Bertolini, Francesco ;
Shaked, Yuval ;
Mancuso, Patrizia ;
Kerbel, Robert S. .
NATURE REVIEWS CANCER, 2006, 6 (11) :833-845
[4]  
Bhagat A.A.S., 2012, 15 INT C MIN SYST CH, P524
[5]   Pinched flow coupled shear-modulated inertial microfluidics for high-throughput rare blood cell separation [J].
Bhagat, Ali Asgar S. ;
Hou, Han Wei ;
Li, Leon D. ;
Lim, Chwee Teck ;
Han, Jongyoon .
LAB ON A CHIP, 2011, 11 (11) :1870-1878
[6]   Inertial microfluidics for continuous particle filtration and extraction [J].
Bhagat, Ali Asgar S. ;
Kuntaegowdanahalli, Sathyakumar S. ;
Papautsky, Ian .
MICROFLUIDICS AND NANOFLUIDICS, 2009, 7 (02) :217-226
[7]   Continuous particle separation in spiral microchannels using dean flows and differential migration [J].
Bhagat, Ali Asgar S. ;
Kuntaegowdanahalli, Sathyakumar S. ;
Papautsky, Ian .
LAB ON A CHIP, 2008, 8 (11) :1906-1914
[8]   Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy [J].
Bidard, F. -C. ;
Mathiot, C. ;
Degeorges, A. ;
Etienne-Grimaldi, M. -C. ;
Delva, R. ;
Pivot, X. ;
Veyret, C. ;
Bergougnoux, L. ;
de Cremoux, P. ;
Milano, G. ;
Pierga, J. -Y. .
ANNALS OF ONCOLOGY, 2010, 21 (09) :1765-1771
[9]   Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer [J].
Bidard, F. -C. ;
Mathiot, C. ;
Delaloge, S. ;
Brain, E. ;
Giachetti, S. ;
de Cremoux, P. ;
Marty, M. ;
Pierga, J. -Y. .
ANNALS OF ONCOLOGY, 2010, 21 (04) :729-733
[10]  
CDRH, OV DEV REG